267 related articles for article (PubMed ID: 18801761)
1. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients.
Cervera R; Khamashta MA; Shoenfeld Y; Camps MT; Jacobsen S; Kiss E; Zeher MM; Tincani A; Kontopoulou-Griva I; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Gromnica-Ihle E; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Roch B; Fernández-Nebro A; Piette JC; Espinosa G; Bucciarelli S; Pisoni CN; Bertolaccini ML; Boffa MC; Hughes GR;
Ann Rheum Dis; 2009 Sep; 68(9):1428-32. PubMed ID: 18801761
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and mortality in the antiphospholipid syndrome.
Espinosa G; Cervera R
Curr Opin Pulm Med; 2009 Sep; 15(5):413-7. PubMed ID: 19436204
[TBL] [Abstract][Full Text] [Related]
4. A study of 75 pregnancies in patients with antiphospholipid syndrome.
Huong DL; Wechsler B; Bletry O; Vauthier-Brouzes D; Lefebvre G; Piette JC
J Rheumatol; 2001 Sep; 28(9):2025-30. PubMed ID: 11550970
[TBL] [Abstract][Full Text] [Related]
5. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome and recurrent thrombosis in children.
Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
[TBL] [Abstract][Full Text] [Related]
7. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe.
Cervera R; Boffa MC; Khamashta MA; Hughes GR
Lupus; 2009 Sep; 18(10):889-93. PubMed ID: 19671788
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
Cervera R; Khamashta MA; Font J; Sebastiani GD; Gil A; Lavilla P; Mejía JC; Aydintug AO; Chwalinska-Sadowska H; de Ramón E; Fernández-Nebro A; Galeazzi M; Valen M; Mathieu A; Houssiau F; Caro N; Alba P; Ramos-Casals M; Ingelmo M; Hughes GR;
Medicine (Baltimore); 2003 Sep; 82(5):299-308. PubMed ID: 14530779
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.
Tan BE; Thong BY; Shivananda S; Han WW; Chng HH
Lupus; 2009 Jul; 18(8):752-8. PubMed ID: 19502274
[TBL] [Abstract][Full Text] [Related]
10. [Warfarin in the treatment of antiphospholipid syndrome].
Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile.
Bertero MT; Bazzan M; Carignola R; Montaruli B; Silvestro E; Sciascia S; Vaccarino A; Baldovino S; Roccatello D;
Lupus; 2012 Jun; 21(7):806-9. PubMed ID: 22635240
[TBL] [Abstract][Full Text] [Related]
12. Primary antiphospholipid syndrome: pregnancy outcome in a portuguese population.
Serrano F; Nogueira I; Borges A; Branco J
Acta Reumatol Port; 2009; 34(3):492-7. PubMed ID: 19820673
[TBL] [Abstract][Full Text] [Related]
13. [Pregnancy in primary antiphospholipid syndrome. Proposal for a common management protocol].
el Kouri D; Winer N; Sagot P; Hamidou M; Boog G; Barrier J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(8):828-31. PubMed ID: 9026512
[TBL] [Abstract][Full Text] [Related]
14. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes.
Van Horn JT; Craven C; Ward K; Branch DW; Silver RM
Placenta; 2004 Aug; 25(7):642-8. PubMed ID: 15193871
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients.
García-Carrasco M; Galarza C; Gómez-Ponce M; Cervera R; Rojas-Rodríguez J; Espinosa G; Bucciarelli S; Gómez-Puerta JA; Bové A; Escárcega RO; Font J
Lupus; 2007; 16(5):366-73. PubMed ID: 17576741
[TBL] [Abstract][Full Text] [Related]
16. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.
Avcin T; Cimaz R; Silverman ED; Cervera R; Gattorno M; Garay S; Berkun Y; Sztajnbok FR; Silva CA; Campos LM; Saad-Magalhaes C; Rigante D; Ravelli A; Martini A; Rozman B; Meroni PL
Pediatrics; 2008 Nov; 122(5):e1100-7. PubMed ID: 18955411
[TBL] [Abstract][Full Text] [Related]
17. Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation?
Derksen RH; de Groot PG
J Autoimmun; 2000 Sep; 15(2):255-9. PubMed ID: 10968920
[TBL] [Abstract][Full Text] [Related]
18. Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome.
Grika EP; Ziakas PD; Zintzaras E; Moutsopoulos HM; Vlachoyiannopoulos PG
J Rheumatol; 2012 Mar; 39(3):516-23. PubMed ID: 22247356
[TBL] [Abstract][Full Text] [Related]
19. Pediatric antiphospholipid antibodies and antiphospholipid syndrome.
Hunt BJ
Semin Thromb Hemost; 2008 Apr; 34(3):274-81. PubMed ID: 18720307
[TBL] [Abstract][Full Text] [Related]
20. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.
Ruffatti A; Tonello M; Cavazzana A; Bagatella P; Pengo V
Thromb Res; 2009; 123(3):482-7. PubMed ID: 18462781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
